See more : Pro Medicus Limited (PME.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tianjin Lisheng Pharmaceutical Co.,Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Xenous Holdings, Inc. (XITO) Income Statement Analysis – Financial Results
- Mirai Works Inc. (6563.T) Income Statement Analysis – Financial Results
- Fuzetec Technology Co., Ltd. (6642.TWO) Income Statement Analysis – Financial Results
- LFTD Partners Inc. (LIFD) Income Statement Analysis – Financial Results
- Reliance Worldwide Corporation Limited (RLLWF) Income Statement Analysis – Financial Results
Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.lishengpharma.com
About Tianjin Lisheng Pharmaceutical Co.,Ltd.
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.15B | 1.15B | 1.09B | 1.14B | 1.62B | 1.50B | 1.03B | 846.85M | 774.78M | 773.73M | 1.04B | 1.12B | 763.64M | 737.97M | 595.70M | 592.54M | 393.29M | 349.44M |
| Cost of Revenue | 468.15M | 486.28M | 454.48M | 439.51M | 447.76M | 427.12M | 378.75M | 365.43M | 346.51M | 347.12M | 369.38M | 428.41M | 299.50M | 295.39M | 218.28M | 241.41M | 119.93M | 105.90M |
| Gross Profit | 684.88M | 660.31M | 637.46M | 701.33M | 1.17B | 1.08B | 650.69M | 481.43M | 428.28M | 426.60M | 675.02M | 688.65M | 464.15M | 442.59M | 377.42M | 351.13M | 273.37M | 243.54M |
| Gross Profit Ratio | 59.40% | 57.59% | 58.38% | 61.48% | 72.28% | 71.59% | 63.21% | 56.85% | 55.28% | 55.14% | 64.63% | 61.65% | 60.78% | 59.97% | 63.36% | 59.26% | 69.51% | 69.69% |
| Research & Development | 105.62M | 105.98M | 104.09M | 76.70M | 123.43M | 94.30M | 102.19M | 64.21M | 33.23M | 41.49M | 39.29M | 40.62M | 25.49M | 23.31M | 17.63M | 17.31M | 12.98M | 0.00 |
| General & Administrative | 27.39M | 26.47M | 28.74M | 29.00M | 34.08M | 28.39M | 23.97M | 20.05M | 10.63M | 20.56M | 26.48M | 25.38M | 23.44M | 17.72M | 16.57M | 14.82M | 13.88M | 64.45M |
| Selling & Marketing | 270.07M | 336.02M | 362.91M | 424.42M | 692.31M | 660.39M | 307.95M | 193.37M | 173.28M | 195.80M | 228.42M | 216.16M | 114.05M | 96.99M | 84.84M | 86.80M | 64.44M | 67.20M |
| SG&A | 297.46M | 362.48M | 391.65M | 453.42M | 726.39M | 688.78M | 331.93M | 213.42M | 183.91M | 216.36M | 254.90M | 241.53M | 137.49M | 114.71M | 101.41M | 101.62M | 78.33M | 131.65M |
| Other Expenses | -138.01M | 108.39M | 96.11M | 113.14M | 121.70M | -1.02M | 200.19K | 2.00M | 2.04M | 4.41M | 5.46M | 5.25M | 889.98K | 3.57M | 6.39M | 256.01K | 1.00M | 691.40K |
| Operating Expenses | 245.26M | 576.85M | 591.85M | 643.26M | 971.53M | 903.13M | 552.36M | 366.21M | 299.84M | 338.34M | 370.17M | 366.77M | 222.26M | 199.64M | 165.43M | 162.75M | 118.47M | 136.52M |
| Cost & Expenses | 733.23M | 1.06B | 1.05B | 1.08B | 1.42B | 1.33B | 931.11M | 731.63M | 646.34M | 685.47M | 739.55M | 795.19M | 521.75M | 495.03M | 383.72M | 404.15M | 238.40M | 242.42M |
| Interest Income | 60.53M | 68.25M | 87.60M | 28.46M | 22.36M | 20.69M | 14.09M | 26.94M | 7.73M | 18.14M | 21.22M | 33.36M | 46.92M | 20.78M | 836.08K | 829.50K | -0.92 | -0.93 |
| Interest Expense | 876.40K | 875.18K | 320.50K | 529.91K | 1.36M | 2.66M | 3.54M | 2.49M | 1.70M | 2.01M | 244.83K | 55.60K | 249.03K | 2.02M | 4.33M | 8.47M | 5.88M | 4.86M |
| Depreciation & Amortization | 67.31M | 66.17M | 60.20M | 63.48M | 60.78M | 54.79M | 56.28M | 49.11M | 25.42M | 25.82M | 23.99M | 25.01M | 16.85M | 17.24M | 17.48M | 17.07M | 14.98M | -12.37M |
| EBITDA | 477.38M | 175.16M | 197.64M | 83.60M | 272.16M | 271.44M | 192.41M | 184.88M | 164.16M | 136.06M | 376.03M | 387.97M | 406.12M | 285.13M | 225.02M | 198.06M | 169.87M | 104.89M |
| EBITDA Ratio | 41.40% | 21.09% | 19.48% | 14.54% | 18.85% | 18.79% | 18.95% | 24.56% | 22.27% | 18.61% | 36.29% | 35.03% | 53.18% | 38.53% | 37.77% | 33.90% | 42.91% | 30.02% |
| Operating Income | 419.81M | 175.67M | 136.91M | 102.35M | 220.15M | 215.01M | 130.63M | 131.29M | 133.62M | 107.78M | 347.97M | 357.99M | 386.01M | 261.52M | 195.28M | 172.37M | 154.74M | 117.25M |
| Operating Income Ratio | 36.41% | 15.32% | 12.54% | 8.97% | 13.63% | 14.30% | 12.69% | 15.50% | 17.25% | 13.93% | 33.32% | 32.05% | 50.55% | 35.44% | 32.78% | 29.09% | 39.34% | 33.55% |
| Total Other Income/Expenses | 408.65K | 299.94K | 212.20K | -97.75K | -3.35M | -1.02M | 200.19K | 2.00M | 1.76M | 4.29M | 5.21M | 44.09M | -11.32K | 3.55M | 3.55M | -13.07M | 959.19K | 648.32K |
| Income Before Tax | 420.21M | 118.36M | 137.12M | 30.93M | 216.79M | 213.99M | 130.83M | 133.28M | 135.38M | 112.07M | 353.18M | 363.08M | 386.77M | 265.07M | 201.55M | 172.52M | 155.70M | 117.90M |
| Income Before Tax Ratio | 36.44% | 10.32% | 12.56% | 2.71% | 13.42% | 14.23% | 12.71% | 15.74% | 17.47% | 14.48% | 33.82% | 32.50% | 50.65% | 35.92% | 33.83% | 29.11% | 39.59% | 33.74% |
| Income Tax Expense | 58.39M | 24.76M | 15.01M | 22.32M | 28.66M | 29.01M | 14.01M | 17.68M | 21.17M | 19.19M | 55.12M | 61.33M | 53.38M | 45.81M | 35.30M | 29.06M | 23.74M | 18.97M |
| Net Income | 361.83M | 93.61M | 122.11M | 8.62M | 188.14M | 184.98M | 116.82M | 115.61M | 114.21M | 92.88M | 298.06M | 297.11M | 324.77M | 203.40M | 154.51M | 132.01M | 132.45M | 100.23M |
| Net Income Ratio | 31.38% | 8.16% | 11.18% | 0.76% | 11.65% | 12.30% | 11.35% | 13.65% | 14.74% | 12.00% | 28.54% | 26.60% | 42.53% | 27.56% | 25.94% | 22.28% | 33.68% | 28.68% |
| EPS | 1.97 | 0.51 | 0.67 | 0.05 | 1.03 | 1.01 | 0.64 | 0.63 | 0.63 | 0.51 | 1.61 | 1.63 | 1.90 | 1.22 | 1.13 | 0.97 | 0.97 | 0.73 |
| EPS Diluted | 1.97 | 0.51 | 0.67 | 0.05 | 1.03 | 1.01 | 0.64 | 0.63 | 0.63 | 0.51 | 1.61 | 1.63 | 1.90 | 1.22 | 1.13 | 0.97 | 0.97 | 0.73 |
| Weighted Avg Shares Out | 183.67M | 182.45M | 182.46M | 182.46M | 182.45M | 182.45M | 182.45M | 182.45M | 181.29M | 182.12M | 181.98M | 182.27M | 182.06M | 166.72M | 136.73M | 136.09M | 136.54M | 137.30M |
| Weighted Avg Shares Out (Dil) | 183.67M | 182.45M | 182.46M | 182.46M | 182.45M | 183.15M | 182.53M | 183.50M | 181.29M | 182.12M | 181.98M | 182.27M | 182.06M | 166.72M | 136.73M | 136.09M | 136.54M | 137.30M |
Source: https://incomestatements.info
Category: Stock Reports